Compare IBI305 and Bevacizumab on Pharmacokinetics/Safety/Immunogenicity on Healthy Male
Clinical trial NCT03083990 · COMPLETED
Trial details
- NCT number
- NCT03083990
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-09
- Primary completion
- 2017-08-17
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.